Member Info for Zoom0001

He's got a point though runner.

When did you initially invest runner, was it @ .13p?

I think anyone with the slightest bit of intuition has probably got a sence of what runner-runner's about.

Who mentioned short?

Long term holder? Very much doubt it having opened this particular LSE account on Nov 19th.

Negative history? Almost , lots of subtle negatives in your posts & I can't imagine it will be long before your true colours come out.

Plenty like you around. Just saying it a I see it.

Long term holder runner-runner? Your short, negative history here would suggest otherwise.

Tiger, your not investing in your own research. You said there has been a leak which you have been privy to.

That’s insider dealing not research. I want the company to succeed as much as the next person, but stop this rubbish. It’s embarrassing.

Tigercake by any chance?

I watched the video Vanv & listened to the comments. I’m not disappointed that they’ve moved to a non invasive nasal swab. Saliva is still in development & may or may not come good. Getting a test out which can be mass produced is all I’m really interested in, regardless of the sample type.

I’m aware. Just trying to be polite.

Maybe Vanv, alternatively, it could be a reaction to the governments requirements. Guess we'll find out soon enough. They are still working with saliva so hopefully we will have 2 tests in tandem to address the huge market opportunity.

Not just the LFD. BAMS could underpin the share price. The scale of government spending on diagnostics indicates to me that they are not placing all of their chips on a vaccine. One successful mutation & it’s back to square 1.

It’s all in the interviews, he said it might be summer, it won’t be Christmas, it won’t take long, maybe a few weeks, it could be a couple of weeks, soon & not long now.

I’m confused, what is it your not clear about?

It’s a gene editing (cutting) therapy. As far as I’m aware it’s been developed by scientists in Israel.

I would say 8, possibly 9. Happy to be corrected though.

Yes, they moved from Micro to small cap.

https://app2.msci.com/eqb/gimi/smallcap/MSCI_Nov20_SCPublicList.pdf

That’s one angle profit & frankly the sale ****ed me off. Having said this, it really doesn’t matter if you stick the test in your mouth or nose, providing it’s easy to use, good spec & non evasive. Maybe, just maybe he sold the shares a the point where he new the test would work & go into production at scale. I guess we’ll find out at some point.

That’s the thing Tony. We’re continually having to read between the lines & have been for the last few months.

Who is or who has? If it’s the latter, I recon it’s Global.

I definitely feels like a coordinated syndicate of bashers have turned up. They must be shorting. There’s no other explanation. I couldn’t be bothered to spend so much time posting on something that I had little interest in if there wasn’t a financial incentive.

AS specifically set timelines & no placing required during the summer presentation. I was already in, but if I was a new investor, I would have bought at around £2.00 based on what was said. Literally, days later they raised around £50 million & the news flow has pretty much dried up since then. Read the RNS about the blocking therapy. “Can potentially be developed quicker than a vaccine” then in the last presentation he’s said that he doesn’t want to “over egg the pudding with that one”. His share sale was also timed appallingly. I think they will get the tests to market but watching the price drop 20% in one day gives people the right to have an alternative opinion.